Projects per year
Fingerprint
Dive into the research topics where Sandrine Aspeslagh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
FWOSB161: FORX - FOod interventions to Reduce immunotherapy toXicity
1/11/23 → 31/10/27
Project: Fundamental
Research output
-
1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Vanlaer, N., Dirven, I., Vounckx, M., Tijtgat, J., Verhaert, M., Aspeslagh, S., Decoster, L., Rogiers, A. & Neyns, B., Oct 2023, In: Annals of Oncology. 34, 1 p., 1860P.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 others, , 2023.Research output: Unpublished contribution to conference › Unpublished abstract
-
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)
Postel-Vinay, S., Lam, V. K., Ros, W., Bauer, T. M., Hansen, A. R., Cho, D. C., Stephen Hodi, F., Schellens, J. H. M., Litton, J. K., Aspeslagh, S., Autio, K. A., Opdam, F. L., McKean, M., Somaiah, N., Champiat, S., Altan, M., Spreafico, A., Rahma, O., Paul, E. M., Ahlers, C. M. & 12 others, , 16 Mar 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3, 16 p., e005301.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review
Wuyts, S. C. M., Cappelle, C. A. H., Verhaert, M., Bravenboer, B. & Aspeslagh, S., 12 Apr 2023, In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.Research output: Contribution to journal › Article › peer-review
-
Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Vanlaer, N., Dirven, I., Vounckx, M., Tijtgat, J., Verhaert, M., Aspeslagh, S., Decoster, L., Rogiers, A. & Neyns, B., Oct 2023.Research output: Unpublished contribution to conference › Poster
Activities
- 1 Talk or presentation at a conference
-
Belgian Multidisciplinary Immunotoxicity Board
Marthe Verhaert (Speaker) & Sandrine Aspeslagh (Speaker)
4 Feb 2022Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors
Author: Cappelle, C. A., Wuyts, S., Verhaert, M., Cortoos, P. & Aspeslagh, S., 2022Student thesis: Master-after-master